Government News

- Read more about Government approved package of Rs 13760 crore for APIs and medical devices
The cabinet has approved four schemes which totally include Rs 13,760 crore to promote the domestic production of active pharmaceutical ingredients (APIs) and medical devices in the country and their exports.
- Read more about Indian Government ban export of hydroxychloroquine
- Read more about Airborne spread of novel coronavirus is not reported yet: WHO
Dr Poonam Khetarpal Singh, regional director of the World Health Organisation (WHO) South-East Asia region, reported that there is no airborne case of the COVID-19 known yet.
- Read more about Health services monitoring for price hike due to COVID-19 in India
Measure of public health prepardeness in respect of APIs / intermediate / KSMs which are closely monitor the production and availability of APIs and their formulations to prevent black marketing and hoarding.

Drug controller cum licensing authority, director of health services, Chandigarh are monitoring for availability of APIs and drugs in context of outbreak of COVID-19 in China. NPPA (National Pharmaceutical pricing authority) chairman had written a letter to Drug Controller, Chandigarh and all the other State's/ UTs Chief Secretaries for taking measures on price control due to COVID-19 outbreak in the country.
- Read more about PCI must be given the power to regulate pharmacy, not AICTE : SC
- Read more about Indian Government restricted export of Paracetamol and other medication due to COVID-19 outbreak
The Government has made amendments in the export policy and restricted export of specified APIs (Active Pharmaceutical Ingredients) and formulations made from 13 APIs for safety purpose due to COVID-19 outbreak in India. A notification issued by Directorate General of Foreign Trade, Commerce and Industry says that the restrictions will come into immediate effect and until further orders.
- Read more about CDSCO launch list of 139 reference products to conduct BE studies
The Central Drugs Standard Control Organisation (CDSCO) has released the list of 139 drug formulations and their reference products permitted by DCGI to conduct bio-equivalence (BE) studies.
- Read more about FICCI suggests India need epharmacy rules
e-Pharmacies strictly do not accept orders for habit forming medicines, narcotics, or any other sensitive medicines. Additionally, given the importance of the e-Pharmacy sector globally, several large investors have recently reached out to the e-Pharmacy players, expressing concern about the general investment and regulatory climate in India
- Read more about Do not prescribe Nimesulide under 12 years of age, urges PvPI
Pharmacovigilance Programme of India (PvPI) urges healthcare professionals to take require measures and do not prescribe Nimesulide for children under 12 years of age. PvPI urges to spread awareness among healthcare professionals to take all necessary precautions in order to avoid such mishappenings and to promote rational use of medicines.
- Read more about Indian Pharmacopoeia officially recognised at Afghanistan
Indian Pharmacopoeia has been recognised formally by the National Department of Regulation of Medicines and Health Products of the Ministry of Public Health of Islamic Republic of Afghanistan. The quality, efficacy and safety of the medicines are important from healthcare prospective. In order to ensure the quality of medicinal products, the legal and scientific standards are provided by Indian Pharmacopoeia Commission (IPC) in the form of Indian Pharmacopoeia (IP).